Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  octreotide pamoate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-6 of 6 for your search:
Start Over
Phase III Randomized, Double-Blind Study of 5-FU/SMS 201-995 pa LAR vs 5-FU/Placebo for Unresectable Stage II or Stage III/IV Pancreatic Cancer (Summary Last Modified 10/97)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SANDOZ-SMSM-304-E-00, NCI-V95-0798
Phase III Randomized Double-Blind Study of Tamoxifen/Octreotide Pamoate vs Tamoxifen/Placebo in Women with Locally Recurrent or Metastatic Breast Cancer (Summary Last Modified 12/98)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SANDOZ-SMST-302, NCI-V96-0934
Study to Investigate the Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CSMS995ADE05, NCT00171873
Evaluation of Octreotide LAR in Prevention of Chemotherapy-induced Diarrhea
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSMS995AIC04, NCT00582426
Phase I Study of Octreotide Pamoate With or Without Tamoxifen in Patients With Osteosarcoma (Summary Last Modified 12/2000)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 25 and under (at time of diagnosis)
Sponsor: NCI
Protocol IDs: NCI-95-C-0119I, NCI-T96-0047N, T96-0047
Start Over